全文获取类型
收费全文 | 6234篇 |
免费 | 2822篇 |
国内免费 | 7篇 |
专业分类
林业 | 123篇 |
农学 | 501篇 |
1458篇 | |
综合类 | 35篇 |
农作物 | 156篇 |
水产渔业 | 2054篇 |
畜牧兽医 | 2932篇 |
园艺 | 1篇 |
植物保护 | 1803篇 |
出版年
2023年 | 2篇 |
2022年 | 3篇 |
2021年 | 117篇 |
2020年 | 476篇 |
2019年 | 913篇 |
2018年 | 798篇 |
2017年 | 851篇 |
2016年 | 658篇 |
2015年 | 621篇 |
2014年 | 570篇 |
2013年 | 831篇 |
2012年 | 958篇 |
2011年 | 556篇 |
2010年 | 499篇 |
2009年 | 221篇 |
2008年 | 244篇 |
2007年 | 109篇 |
2006年 | 99篇 |
2005年 | 104篇 |
2004年 | 92篇 |
2003年 | 84篇 |
2002年 | 82篇 |
2001年 | 77篇 |
2000年 | 91篇 |
1999年 | 4篇 |
1989年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
排序方式: 共有9063条查询结果,搜索用时 15 毫秒
21.
Comparative,multidimensional imaging of patent ductus arteriosus and a proposed update to the morphology classification system for dogs 下载免费PDF全文
22.
23.
24.
25.
26.
27.
Effect of benazepril and pimobendan on serum angiotensin‐converting enzyme activity in dogs 下载免费PDF全文
J. N. King C. Christinaz G. Strehlau J. Hornfeld 《Journal of veterinary pharmacology and therapeutics》2018,41(3):485-489
To support their combined use, the objective of the study was to evaluate the effects of benazepril and pimobendan on serum angiotensin‐converting enzyme (ACE) activity in dogs. A total of 48 healthy beagle dogs were randomized into four groups (n = 12 per group) in a parallel‐group design study: A (control, placebo twice daily (BID)); B (0.5–1.0 mg/kg benazepril once daily (SID) in the morning, placebo in the evening); C (0.25–0.5 mg/kg benazepril BID); D (0.25–0.5 mg/kg benazepril and 0.125–0.25 mg/kg pimobendan, both BID). The test items were administered orally for 15 days. Serum ACE activity was measured on days 1 and 15. Groups B, C and D had significantly lower average serum ACE activity compared to baseline and to the control group, on both days 1 and 15. There were no significant differences in average ACE activity between groups B, C and D. Noninferiority of group C to B was demonstrated. In conclusion, 0.25–0.5 mg/kg benazepril administered BID produced noninferior inhibition of serum ACE activity compared to 0.5–1.0 mg/kg benazepril dosed SID. Pimobendan had no significant effect on benazepril's action on serum ACE activity. The results support the use of benazepril BID in dogs and in combination with pimobendan. 相似文献
28.
Integration of pharmacokinetic–pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs 下载免费PDF全文
Y. Wang A. Sajid S. Ahmed X. Li 《Journal of veterinary pharmacology and therapeutics》2018,41(5):706-718
The aims of this study were to establish optimal doses of doxycycline (dox) against Haemophilus parasuis on the basis of pharmacokinetic–pharmacodynamic (PK‐PD) integration modeling. The infected model was established by intranasal inoculation of organism in pigs and confirmed by clinical signs, blood biochemistry, and microscopic examinations. The recommended dose (20 mg/kg b.w.) was administered in pigs through intramuscular routes for PK studies. The area under the concentration 0‐ to 24‐hr curve (AUC0–24), elimination half‐life (T½ke), and mean residence time (MRT) of dox in healthy and H. parasuis‐infected pigs were 55.51 ± 5.72 versus 57.10 ± 4.89 μg·hr/ml, 8.28 ± 0.91 versus 9.80 ± 2.38 hr, and 8.43 ± 0.27 versus 8.79 ± 0.18 hr, respectively. The minimal inhibitory concentration (MIC) of dox against 40 H. parasuis isolates was conducted through broth microdilution method, the corresponding MIC50 and MIC90 were 0.25 and 1 μg/ml, respectively. The Ex vivo growth inhibition data suggested that dox exhibited a concentration‐dependent killing mechanism. Based on the observed AUC24 hr/MIC values by modeling PK‐PD data in H. parasuis‐infected pigs, the doses predicted to obtain bacteriostatic, bactericidal, and elimination effects for H. parasuis over 24 hr were 5.25, 8.55, and 10.37 mg/kg for the 50% target attainment rate (TAR), and 7.26, 13.82, and 18.17 mg/kg for 90% TAR, respectively. This study provided a more optimized alternative for clinical use and demonstrated that the dosage 20 mg/kg of dox by intramuscular administration could have an effective bactericidal activity against H. parasuis. 相似文献
29.
Pharmacokinetics of multiple doses of transdermal flunixin meglumine in adult Holstein dairy cows 下载免费PDF全文
M. D. Kleinhenz P. J. Gorden J. S. Smith J. A. Schleining K. E. Kleinhenz L. L. Wulf P. K. Sidhu D. Rea J. F. Coetzee 《Journal of veterinary pharmacology and therapeutics》2018,41(3):490-493
A transdermal formulation of the nonsteroidal anti‐inflammatory drug, flunixin meglumine, has been approved in the United States and Canada for single‐dose administration. Transdermal flunixin meglumine was administered to 10 adult Holstein cows in their second or third lactation at the label dose of 3.33 mg/kg every 24 hr for three total treatments. Plasma flunixin concentrations were determined using high‐pressure liquid chromatography with mass spectroscopy (HPLC ‐MS ). Pharmacokinetic analysis was completed on each individual animal with noncompartmental methods using computer software. The time to maximum drug concentration (T max) was 2.81 hr, and the maximum drug concentration was 1.08 μg/ml. The mean terminal half‐life (T½) was determined to be 5.20 hr. Clearance per fraction absorbed (Cl/F) was calculated to be 0.294 L/hr kg?1, and volume of distribution of fraction (V z/F ) absorbed was 2.20 L/kg. The mean accumulation factor was 1.10 after three doses. This indicates changes in dosing may not be required when giving multiple doses of flunixin transdermal. Further work is required to investigate the clinical efficacy of transdermal flunixin after multiple daily doses. 相似文献
30.
Comparison between the urine dipstick and the pH‐meter to assess urine pH in sheep and dogs 下载免费PDF全文